Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Svenska Aerogel to become exclusive supplier of aerogel material for patented, high-performance toothpaste for sensitivity

Svenska Aerogel is set to be the exclusive manufacturer of a new aerogel material for use in a patented toothpaste for sensitive teeth within the premium segment. This material was developed during a multi-year collaboration between Svenska Aerogel, a leading London university, and a global healthcare company. When tested, the toothpaste containing the material has proven to be more than 44 times faster-acting than market-leading toothpastes for sensitivity. Matrix, a UK-based company specializing in the commercialization of personal care products and brands, is now preparing to launch the

Watch Quickbit’s investor presentation from November 28, 2023

Yesterday, November 28, 2023,  Quickbit held a presentation with subsequent Q&A. The presentation was held digitally and in Swedish. CEO Daniel Sonesson and Chairman Peter Liljeroos told more about Quickbit’s expanded collaboration with Paysecure and outlined the way forward. Quickbit also answered questions submitted in advance and during the presentation. The presentation is now available digitally via the following link:https://youtu.be/v7nkyjtf5n8 For further information, please contact: Daniel Sonesson, CEO  + 46 73 530 30 25ir@quickbit.com    -------------------

Genexis Group expands board with two new board members

Genexis Group AB has as of November 23, 2023 formally registered two new independent board members. The new board members are Angelique Schouten and Jonas Hasselberg.Angelique is currently CEO and Founder of 10x.team. Angelique brings a vast experience from multiple technology ventures and her board positions at Joanna Invests, AI.nl and Holland FinTech. Jonas is currently CEO and President of Proact IT. He brings extensive experience from broadband and telecommunication industry from, among others, Nokia, Microsoft and Telia. The full board consists of Daniel Winberg, Chairman

Correction: Greenfood’s Interim report third quarter 2023

Greenfood would like to issue a correction regarding our recently published interim report on November 24, 2023. We have identified and rectified a few inadvertent errors in the document. · · On page 1, in the Interim overview section, the original text “SEK -6.1 million came from un-established operations” was mistakenly written. The correct text should read “SEK -9.2 million came from un-established operations”. · On page 1, the original text “Group net result SEK -168.9 (97.7) million” is missing a minus sign. The correct text is “Group net result SEK -168.9 (-97.7)

Reminder: Circio invites to circular RNA R&D webinar today

Oslo, Norway, 29 November 2023 – Circio Holding ASA (OSE: CRNA) Circio's management invites to a live R&D webinar featuring a KOL presentation by circular RNA pioneer and founder of oRNA Therapeutics, Dr. Alexander Wesselhoeft, today at 10am EST / 4pm CET. Webinar details: Date: Wednesday 29 November 2023Time: 10am EST / 4pm CET, duration ~75-90 minutesWebinar Click here for webinar link (https://teams.microsoft.com/l/meetuplink: -join/19%3ameeting_OGNlNmM1ZjMtMmI5Zi00ZTM0LWJiOTAtYzUyNmE4OWE1Zjcx%4 0thre ad.v2/0?context=%7b%22Tid%22%3a%2266b0661a-

Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in life science research and clinical diagnostics products. Their customers include universities, research institutions, hospitals, food safety and environmental quality laboratories around the world. During the fall of 2022, a dialogue was initiated between Glycorex and Bio-Rad to evaluate Glycosorb® ABO as part of their manufacturing process for polyclonal reagents for rare blood groups. Donor plasma containing the specific antibody is used to produce these reagents. Since donors are typically of blood groups O, A, or

E-scooter riders reminded ‘Don’t drink and scoot’ this Christmas

Credit: Voi As seasonal festivities approach, rental e-scooter operator, Voi, has a clear message for riders - alcohol and e-scooters don’t mix and anyone caught drink-scooting could lose their driving licence. Riding an e-scooter under the influence of alcohol not only puts the rider at risk, but other road users too, so Voi will be reminding riders of the dangers, especially during the run up to Christmas when it expects to see more people riding to get to social events. The same alcohol limits for driving motor vehicles in the UK also apply to e-scooters. Anyone

Kiilto received its thirteenth Achievers certificate – Being awarded the rare Recurring Achievers badge is the result of the work of every Kiiltonian

Less than 1% of companies are awarded the Achievers certificate for more than 10 consecutive years. Kiilto received its thirteenth Achievers certificate and is one of the rare Recurring Achievers companies.The certificate was awarded to the Kiilto Family Group by Kauppalehti. Kauppalehti is a Finnish commerce-oriented newspaper that has been in circulation since 1898. For the Achievers certificate, a financial analyst evaluates the company and awards the certificate if they find that the company is performing better than its peers. To obtain the certificate, the financial situation of

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China

Press Release – Oslo, Norway, November 29, 2023: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated today that the National Medical Products Administration (NMPA) accepted the new drug application (NDA) for Hexvix[®] (APL-1706) in China. Hexvix, a pharmaceutical product used in the detection of bladder cancer, was licensed to Asieris by Photocure in January 2021, for the registration and commercialization of Hexvix in mainland China and Taiwan.Results of the Hexvix (APL-1706) Phase III clinical trial in China

31 new Wallenberg Academy Fellows tackle issues in future research

This year, Knut and Alice Wallenberg Foundation has appointed 31 young researchers Wallenberg Academy Fellows, meaning that they will receive five years of funding and the opportunity to benefit from a unique mentoring program. Will future computers operate solely using light? Could human hearts be healed in the same way as those of ribbed newts? How do dwarf galaxies form and develop, and how can we improve the assessment of risk probabilities linked to catastrophes? These are just a few of the research questions that this year’s Wallenberg Academy Fellows will be examining. "

Zaplox introduces its latest product - Reservations API enables a more flexible guest journey

Zaplox AB (”Zaplox”) is excited to unveil its latest product - Reservations API. The new launch, consisting of one API with a set of methods, offers hotel brands and hospitality tech suppliers simplified access to multiple Property Management Systems (“PMS”) through one single connection.Zaplox Reservations API not only presents hotels with great development savings and ease of implementation but also offers hotels greater business flexibility as they’re not limited to their current tech stack. Kim Lood CTO at Zaplox, highlights the API’s efficiency, “Without the Reservations API,

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 209 - 29 NOVEMBER 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 186/23 and 187/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Agreement signed with Norrtåg and Real Rail regarding sensors on vehicles

Railway Metrics and Dynamics AB has signed a collaboration and cooperation agreement with Norrtåg and Real Rail within the framework of the Swedish Transport Administration's innovation initiative Mätning av Anläggning från Järnvägsfordon.Railway Metrics and Dynamics is a procured supplier to the Swedish Transport Administration in an innovation project where the goal is to create a continuous facility monitoring of the Swedish railway. The procurement – "Innovation procurement - Regarding further development, validation and delivery of new information services for automated measurement of

B. Braun orders two DrugLog™ for new installations in Spain

B. Braun Medical Spain orders DrugLog™ systems for quality control of compounded medications in 2 additional hospitals.B. Braun Medical Spain orders two complete DrugLog™ systems based on the new hardware platform for installation at additional hospitals in Spain. The DrugLog™ systems will be used to verify the identity and concentration of prepared injectable drugs before they are administered to patients and will contribute to increased patient safety. Lars Gusch, CEO of Pharmacolog comments: "We are very pleased to deliver Pharmacolog's products to two more of B.Braun's customers in

Hamlet BioPharma receives U.S. FDA Fast Track designation for Alpha 1H for the treatment of non-muscle invasive bladder cancer

Lund, Sweden, November 29, 2023. Hamlet BioPharma AB (publ), the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its drug candidate Alpha1H for the treatment of non-muscle invasive bladder cancer. The U.S. FDA Fast Track Designation accelerates the approval process for Alpha 1H and potential for reaching the US market.Hamlet BioPharma has been working closely together with its US partner Target Health, receiving the FDA’s ‘Fast Track

Data Ductus awarded contract from leading Danish communication services provider Nuuday

The Swedish IT consulting company Data Ductus has been awarded a contract for the support and setup of a new network automation platform by Danish communication services provider Nuuday. The contract, which is for an initial one year, began on August 1[st], 2023.Data Ductus is proud to announce its latest contract agreement as it continues to expand its network automation and orchestration offering across Europe. The contract, signed with leading Danish communication services provider Nuuday, is for the support and setup of a new network automation platform. “Nuuday serves 5.8 million

2020 Bulkers Ltd. (2020) – Conversion of index-linked time charters

Oslo, Norway, November 29, 2023, 2020 Bulkers has converted the index-linked time charters for Bulk Sandefjord, Bulk Shenzhen, Bulk Sydney and Bulk Santos to fixed rate time charters for certain periods starting December 1, 2023 and ending March 31, 2024 as summarized below: 3 vessels fixed for December 2023, at average US$20,841 per day, gross. 4 vessels fixed for January 2024, at average US$19,831 per day, gross. 4 vessels fixed for February 2024, at average US$19,831 per day, gross. 3 vessels fixed for March 2024, at average US$19,177 per day, gross. In addition, all

BioStock: Chordate installs system in Germany and launches in the UAE

Chordate Medical has secured an agreement for the installation of the migraine treatment Ozilia at a private specialist clinic in Germany. This follows from the active work of the company's marketing consultants who are introducing the treatment to the German market. In addition, Chordate Medical has recently contracted a market expert in the United Arab Emirates for introduction of the migraine and rhinitis treatment. CEO Anders Weilandt tells us more in an interview.Read the full article at biostock.se: https://www.biostock.se/en/2023/11/chordate-installs-system-in-germany-and-launches-

New study reveals the potential of recycled plastic in food packaging

Orthex Corporation, Press release, 29 November 2023 at 10.15 a.m. EETOrthex and Fortum have joined forces in the SULKI research project, which is part of SPIRIT (Sustainable Plastics Industry Transformation) programme supported by Business Finland and driven by Borealis with the aim to transform the plastics industry towards a more sustainable future. As a part of the SPIRIT programme, Orthex and Fortum are researching in collaboration with other partners whether recycled plastic could be used in products suitable for food contact. Orthex and Fortum have been collaborating on

Invitation to a webinar about Crunchfish’s interim report for Q3 2023

On Thursday, November 30 at 08.30 CET / 13.00 IST, Crunchfish publishes its interim report for Q3 2023. At 09.00 CET / 13.30 IST, a webinar about the report will be hosted on Zoom where Crunchfish CEO Joachim Samuelsson will be interviewed by analyst Filip Stenberg from Västra Hamnen Corporate Finance.   In order to participate in this webinar, registration is done via the following link .   A recording of this webinar will also be available afterward on Crunchfish’s  website

Harder to get access to external credit for companies according to Krea's latest financing report

Krea's new financing report shows that companies increasingly have problems securing external credit. In the past two years, the approval rate for creditworthy companies has dropped from 89% in Q4 2021 to 70% in Q3 2023. Although the approval rate stopped falling in Q3 2023, the future is still uncertain for Swedish entrepreneurs.The financing report for companies is made with the aim of providing a picture of the credit market for small and medium-sized companies in Sweden. The insights in the report, which are based on data from applications on Krea's platform between 2019-2023, show,

CapMan Residential Fund invests in newly built residential property Køhlers Have, in South Harbour area, Copenhagen

CapMan Real Estate press release29.11.2023 at 10:00 AM EET CapMan Residential Fund invests in newly built residential property Køhlers Have, in South Harbour area, Copenhagen CapMan Residential Fund (CMRF) invests in Køhlers Have, a newly built residential property located in the attractive South Harbour area of Copenhagen. The high-quality core residential property holds 384 apartments and two commercial units. The property will be DGNB Gold (new construction) certified. This is the sixth investment for CapMans pan-Nordic core residential fund. The investment is well-

There are no items matching the current filter
There are no more items matching the current filter
Back to top